Unilateral Primary Congenital Lymphedema of the Upper Limb in an 11-Month-Old Infant: A Clinical and Pharmacological Perspective
DOI:
https://doi.org/10.3889/oamjms.2018.261Keywords:
Congenital lymphedema, Decongestive therapy, PharmacotherapyAbstract
BACKGROUND: Lymphedema is the accumulation of a protein-rich fluid in the interstitial space due to reduced lymph transport capacity. Congenital primary lymphedema affecting only one of the upper limbs is a rarity.
CASE REPORT: We present a case of an 11-month-old infant presenting with swelling of the right upper limb, which had gradually progressed over the past five months. Lymphoscintigraphy was suggestive of lymphatic blockade in the right upper limb. All other investigations were within normal limits. A diagnosis of primary congenital lymphedema affecting the right upper limb was made. The patient was managed conservatively with complex decongestive therapy and was requested regular follow-up. The lymphedema did not increase within four months of follow-up.
CONCLUSIONS: Complex decongestive therapy is the cornerstone of the management of primary congenital lymphedema. New investigational therapies such as leukotriene B4 antagonists hold a promise for patients with lymphedema.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Szuba A, Rockson SG. Lymphedema: classification, diagnosis and therapy. Vasc Med. 1998; 3:145-156. https://doi.org/10.1177/1358836X9800300209 PMid:9796078
Jones GE, Mansour S. An approach to familial lymphoedema. Clin Med (Lond). 2017; 17:552-557. https://doi.org/10.7861/clinmedicine.17-6-552 PMid:29196357
Heinig B, Lotti T, Tchernev G, Wollina U. Hereditary lymphedema of the leg – a case report. Open Access Maced J Med Sci. 2017; 5:451-453. https://doi.org/10.3889/oamjms.2017.082 PMid:28785330 PMCid:PMC5535655
MEC McFarlane. Primary upper limb lymphedema: case report of a rare pathology. Perm J. 2017; 21:16-010. https://doi.org/10.7812/TPP/16-010
Smeltzer DM, Sticker GB, Schirger A. Primary lymphedema in children and adolescents; a follow-up study and review. Pediatrics. 1985; 76:206-218. PMid:4022694
Goss JA, Maclellan RA, Beijnen UEA, Greene AK. Resolution of primary lymphedema: a case report. Plast Reconstr Surg Glob Open. 2017; 5:e1223. https://doi.org/10.1097/GOX.0000000000001223 PMid:28280665 PMCid:PMC5340480
Brouillard P, Boon L, Vikkula M. Genetics of lymphatic anomalies. J Clin Invest. 2014; 124:898-904. https://doi.org/10.1172/JCI71614 PMid:24590274 PMCid:PMC3938256
Mendola A, Schlögel MJ, Ghalamkarpour A, Irrthum A, Nguyen HL, Fastré E, Bygum A, Van Der Vleuten C, Fagerberg C, Baselga E, Quere I. Mutations in the VEGFR3 signalling pathway explain 36% of familial lymphedema. Molecular syndromology. 2013; 4(6):257-66. https://doi.org/10.1159/000354097 PMid:24167460 PMCid:PMC3776465
Simonian SJ, Morgan CL, Tretbar LL, Blondeau B. Differential diagnosis of lymphedema. In: Lymphedema: diagnosis and treatment (Tretbar LL, Morgan CL, Lee BB, Simonian SJ, Blondeau B, eds.). Springer, London, UK, 2007:12-20.
Korpan MI, Crevenna R, Fialka-Moser V. Lymphedema: a therapeutic approach in the treatment and rehabilitation of cancer patients. Am J Phys Med Rehabil. 2011; 90:S69-75. https://doi.org/10.1097/PHM.0b013e31820be160 PMid:21765266
Ogawa Y. Recent advances in medical treatment of lymphedema. Ann Vasc Dis. 2012; 5:139-144. https://doi.org/10.3400/avd.ra.12.00006
Takeda K, Sowa Y, Nishino K, Itoh K, Fushiki S. Adipose-derived stem cells promote proliferation, migration, and tube formation of lymphatic endothelial cells in vitro by secreting lymphangiogenic factors. Ann Plast Surg. 2015; 74:728-736. https://doi.org/10.1097/SAP.0000000000000084 PMid:24401810
Tian W, Rockson SG, Jiang X, Kim J, Begaye A, Shuffle EM, et al. Leukotriene B4 antagonism ameliorates experimental lymphedema. Sci Transl Med. 2017; 9:eaal3920.
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
